Skip to main content
Top
Published in: AIDS and Behavior 2/2013

01-10-2013 | Original Paper

Jails, HIV Testing, and Linkage to Care Services: An Overview of the EnhanceLink Initiative

Authors: Anne C. Spaulding, Cristina A. Booker, Shalonda H. Freeman, Sarah W. Ball, Matthew S. Stein, Alison O. Jordan, Divya Ahuja, Liza Solomon, Paula M. Frew

Published in: AIDS and Behavior | Special Issue 2/2013

Login to get access

Abstract

Over 9 million persons in the United States (US) are admitted each year to jails. HIV prevalence among detainees is higher than the general population, which creates a public health need for linking HIV-infected detainees to services during jail and after release. The EnhanceLink initiative was funded as demonstration projects in 10 communities at 20 separate jails across the US. Grantees implemented and evaluated innovative models of HIV testing in jails and linkage of HIV-infected individuals to community services post release. In this paper, we describe services delivered with the EnhanceLink initiative. During 877,119 admission events, 210,267 inmates agreed to HIV testing and 822 new diagnoses of HIV were made. The majority of persons served with transitional services were previously diagnosed before the current incarceration. Cumulatively, 9,837 HIV+ persons were offered linkage and transitional services and 8,056 (82 %) accepted the offer. EnhanceLink demonstrated the feasibility of HIV testing in jail settings and provision of linkage services to enhance continuity of HIV care post-release.
Appendix
Available only for authorised users
Literature
1.
go back to reference Grinstead OA, Zack B, Faigeles B, Grossman N, Blea L. Reducing postrelease HIV risk among male prison inmates: a peer-led intervention. Crim Justice Behav. 1999;26(4):453–65.CrossRef Grinstead OA, Zack B, Faigeles B, Grossman N, Blea L. Reducing postrelease HIV risk among male prison inmates: a peer-led intervention. Crim Justice Behav. 1999;26(4):453–65.CrossRef
2.
go back to reference Hammett TM, Gaiter JL, Crawford C. Reaching seriously at-risk populations: health interventions in criminal justice settings. Health Educ Behav. 1998;25(1):99–120.PubMedCrossRef Hammett TM, Gaiter JL, Crawford C. Reaching seriously at-risk populations: health interventions in criminal justice settings. Health Educ Behav. 1998;25(1):99–120.PubMedCrossRef
3.
go back to reference Spaulding A, Stephenson B, Macalino G, Ruby W, Clarke JG, Flanigan TP. Human immunodeficiency virus in correctional facilities: a review. Clin Infect Dis. 2002;35(3):305–12.PubMedCrossRef Spaulding A, Stephenson B, Macalino G, Ruby W, Clarke JG, Flanigan TP. Human immunodeficiency virus in correctional facilities: a review. Clin Infect Dis. 2002;35(3):305–12.PubMedCrossRef
4.
go back to reference Glaser JB, Greifinger RB. Correctional health care: a public health opportunity. Ann Intern Med. 1993;118(2):139–45.PubMedCrossRef Glaser JB, Greifinger RB. Correctional health care: a public health opportunity. Ann Intern Med. 1993;118(2):139–45.PubMedCrossRef
5.
go back to reference Hammett TM. Making the case for health interventions in correctional facilities. J Urban Health. 2001;78(2):236–40.PubMedCrossRef Hammett TM. Making the case for health interventions in correctional facilities. J Urban Health. 2001;78(2):236–40.PubMedCrossRef
6.
go back to reference Farley JL, Mitty JA, Lally MA, et al. Comprehensive medical care among HIV-positive incarcerated women: the Rhode Island experience. J Womens Health Gend-Based Med. 2000;9(1):51–6.PubMedCrossRef Farley JL, Mitty JA, Lally MA, et al. Comprehensive medical care among HIV-positive incarcerated women: the Rhode Island experience. J Womens Health Gend-Based Med. 2000;9(1):51–6.PubMedCrossRef
7.
go back to reference Flanigan TP, Rich JD, Spaulding A. HIV care among incarcerated persons: a missed opportunity [comment]. AIDS. 1999;13(17):2475–6.PubMedCrossRef Flanigan TP, Rich JD, Spaulding A. HIV care among incarcerated persons: a missed opportunity [comment]. AIDS. 1999;13(17):2475–6.PubMedCrossRef
8.
go back to reference Draine J, Ahuja D, Altice FL, et al. Strategies to enhance linkages between care for HIV/AIDS in jail and community settings. AIDS Care. 2011;23(3):366–77.PubMedCrossRef Draine J, Ahuja D, Altice FL, et al. Strategies to enhance linkages between care for HIV/AIDS in jail and community settings. AIDS Care. 2011;23(3):366–77.PubMedCrossRef
9.
go back to reference Flanigan TP, Zaller N, Beckwith CG, et al. Testing for HIV, sexually transmitted infections, and viral hepatitis in jails: still a missed opportunity for public health and HIV prevention. J Acquir Immune Defic Syndr. 2010;55(Suppl 2):S78–83. Flanigan TP, Zaller N, Beckwith CG, et al. Testing for HIV, sexually transmitted infections, and viral hepatitis in jails: still a missed opportunity for public health and HIV prevention. J Acquir Immune Defic Syndr. 2010;55(Suppl 2):S78–83.
10.
go back to reference Spaulding AC, Seals RM, Page MJ, Brzozowski AK, Rhodes W, Hammett TM. HIV/AIDS among inmates of and releasees from US correctional facilities, 2006: declining share of epidemic but persistent public health opportunity. PLoS ONE. 2009;4(11):e7558.PubMedCrossRef Spaulding AC, Seals RM, Page MJ, Brzozowski AK, Rhodes W, Hammett TM. HIV/AIDS among inmates of and releasees from US correctional facilities, 2006: declining share of epidemic but persistent public health opportunity. PLoS ONE. 2009;4(11):e7558.PubMedCrossRef
11.
go back to reference Westergaard RP, Kirk GD, Richesson DR, Galai N, Mehta SH. Incarceration predicts virologic failure for HIV-infected injection drug users receiving antiretroviral therapy. Clin Infect Dis. 2011;53(7):725–31.PubMedCrossRef Westergaard RP, Kirk GD, Richesson DR, Galai N, Mehta SH. Incarceration predicts virologic failure for HIV-infected injection drug users receiving antiretroviral therapy. Clin Infect Dis. 2011;53(7):725–31.PubMedCrossRef
12.
go back to reference Springer SA, Spaulding AC, Meyer JP, Altice FL. Public health implications for adequate transitional care for HIV-infected prisoners: five essential components. Clin Infect Dis. 2011;53(5):469–79.PubMedCrossRef Springer SA, Spaulding AC, Meyer JP, Altice FL. Public health implications for adequate transitional care for HIV-infected prisoners: five essential components. Clin Infect Dis. 2011;53(5):469–79.PubMedCrossRef
13.
go back to reference Sperling C, Pierce A, Hall T, Tomlin J, Williams S. Intervening with substance using men newly released from jail challenges and strategies. In: National STD conference 2004. Sperling C, Pierce A, Hall T, Tomlin J, Williams S. Intervening with substance using men newly released from jail challenges and strategies. In: National STD conference 2004.
14.
go back to reference Zaller ND, Holmes L, Dyl AC, et al. Linkage to treatment and supportive services among HIV-positive ex-offenders in Project Bridge. J Health Care Poor Underserved. 2008;19(2):522–31.PubMedCrossRef Zaller ND, Holmes L, Dyl AC, et al. Linkage to treatment and supportive services among HIV-positive ex-offenders in Project Bridge. J Health Care Poor Underserved. 2008;19(2):522–31.PubMedCrossRef
15.
go back to reference Rich JD, Holmes L, Salas C, et al. Successful linkage of medical care and community services for HIV-positive offenders being released from prison. J Urban Health. 2001;78(2):279–89.PubMedCrossRef Rich JD, Holmes L, Salas C, et al. Successful linkage of medical care and community services for HIV-positive offenders being released from prison. J Urban Health. 2001;78(2):279–89.PubMedCrossRef
16.
go back to reference Centers for Disease Control and Prevention. Framework for Program Evaluation in Public Health. MMWR 1999;48(No. RR-11). Centers for Disease Control and Prevention. Framework for Program Evaluation in Public Health. MMWR 1999;48(No. RR-11).
18.
go back to reference Robillard A, Garner J, Laufer F. CDC/HRSA HIV/AIDS intervention, prevention, and continuity of care demonstration project for incarcerated individuals within correctional settings and the community: part I, a description of correctional demonstration project activities. J Correct Health Care. 2003;9:453–86.CrossRef Robillard A, Garner J, Laufer F. CDC/HRSA HIV/AIDS intervention, prevention, and continuity of care demonstration project for incarcerated individuals within correctional settings and the community: part I, a description of correctional demonstration project activities. J Correct Health Care. 2003;9:453–86.CrossRef
19.
go back to reference CDC. Assessment of sexually transmitted diseases services in city and county jails—United States, 1997. Morb Mortal Wkly Rep. 1998;47(21):429–31. CDC. Assessment of sexually transmitted diseases services in city and county jails—United States, 1997. Morb Mortal Wkly Rep. 1998;47(21):429–31.
20.
21.
go back to reference de Voux A, Spaulding AC, Beckwith C, et al. Early identification of HIV: empirical support for jail-based screening. PLoS ONE. 2012;7(5):e37603. de Voux A, Spaulding AC, Beckwith C, et al. Early identification of HIV: empirical support for jail-based screening. PLoS ONE. 2012;7(5):e37603.
Metadata
Title
Jails, HIV Testing, and Linkage to Care Services: An Overview of the EnhanceLink Initiative
Authors
Anne C. Spaulding
Cristina A. Booker
Shalonda H. Freeman
Sarah W. Ball
Matthew S. Stein
Alison O. Jordan
Divya Ahuja
Liza Solomon
Paula M. Frew
Publication date
01-10-2013
Publisher
Springer US
Published in
AIDS and Behavior / Issue Special Issue 2/2013
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-012-0339-2

Other articles of this Special Issue 2/2013

AIDS and Behavior 2/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.